Income Statement KPJ Healthcare

Stocks

KPJ

MYL5878OO003

Healthcare Facilities & Services

Delayed BURSA MALAYSIA Other stock markets 06:53:02 17/07/2026 am IST			5-day change	1st Jan Change
3.170 ^MYR	-0.31%		0.00%	+17.84%

14/07	Phillip Capital Starts KPJ Healthcare at Buy with MYR3.80 Price Target	MT
22/06	KPJ Healthcare Berhad Announces Resignation of Hana Binti AB Rahim @ Ali as Joint Secretary, Effective June 22, 2026	CI

c03050.5RGQ7M0EWx7cwbCmp9gXGEoQtwniAZEpLAYEuwW7cW4.1yG9rf52IUqXrtqX1L1vdi5G82C2b6VFFEN9wUODHA2DWsKGvm9vLr2z_Q

Published financial data: KPJ HEALTHCARE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	262.68Cr	292.07Cr	341.87Cr	392.22Cr	425.84Cr
Total Revenues	262.68Cr	292.07Cr	341.87Cr	392.22Cr	425.84Cr
Cost of Goods Sold, Total	168.68Cr	175.12Cr	198.68Cr	216.69Cr	236.03Cr
Gross Profit	94Cr	116.95Cr	143.19Cr	175.54Cr	189.81Cr
Selling General & Admin Expenses, Total	71Cr	80Cr	96Cr	111.27Cr	123.68Cr
Other Operating Expenses	-2.48Cr	-2.33Cr	-6.73Cr	-2.75Cr	-4.25Cr
Other Operating Expenses, Total	69Cr	78Cr	89Cr	108.52Cr	119.43Cr
Operating Income	25Cr	39Cr	54Cr	67Cr	70Cr
Interest Expense, Total	-17Cr	-20Cr	-20Cr	-20Cr	-19Cr
Interest And Investment Income	86.83L	1.22Cr	2.01Cr	2.21Cr	2.11Cr
Net Interest Expenses	-16Cr	-18Cr	-18Cr	-17Cr	-17Cr
Income (Loss) On Equity Invest.	2.59Cr	4.78Cr	4.68Cr	4.94Cr	4.88Cr
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	12Cr	25Cr	40Cr	54Cr	58Cr
Impairment of Goodwill	-40.28L	-	-	-	-
Gain (Loss) On Sale Of Assets	6L	20.64L	-	-	-
Asset Writedown	33.37L	99.89L	-2.08Cr	-80.91L	-1Cr
EBT, Incl. Unusual Items	12Cr	27Cr	38Cr	54Cr	57Cr
Income Tax Expense	5.21Cr	7.59Cr	7.84Cr	17Cr	17Cr
Earnings From Continuing Operations	6.57Cr	19Cr	30Cr	36Cr	40Cr
Earnings Of Discontinued Operations	-	0	-1.79Cr	2.27Cr	-94T
Net Income to Company	6.57Cr	19Cr	28Cr	39Cr	40Cr
Minority Interest	-1.46Cr	-1.83Cr	-2.13Cr	-3.37Cr	-3.55Cr
Net Income - (IS)	5.1Cr	17Cr	26Cr	35Cr	37Cr
Net Income to Common Incl Extra Items	5.1Cr	17Cr	26Cr	35Cr	37Cr
Net Income to Common Excl. Extra Items	5.1Cr	17Cr	28Cr	33Cr	37Cr
Per Share Items
Net EPS - Basic	0.01	0.04	0.06	0.08	0.08
Basic EPS - Continuing Operations	0.01	0.04	0.06	0.08	0.08
Basic Weighted Average Shares Outstanding	429.2Cr	434.14Cr	436.1Cr	436.43Cr	437.39Cr
Net EPS - Diluted	0.01	0.04	0.06	0.08	0.08
Diluted EPS - Continuing Operations	0.01	0.04	0.06	0.08	0.08
Diluted Weighted Average Shares Outstanding	441.58Cr	444.38Cr	436.1Cr	436.43Cr	437.74Cr
Normalized Basic EPS	0.01	0.03	0.05	0.07	0.07
Normalized Diluted EPS	0.01	0.03	0.05	0.07	0.07
Dividend Per Share	0.01	0.02	0.03	0.04	0.04
Payout Ratio	46.49	50.5	55.5	51.19	50.45
Supplemental Items
EBITDA	44Cr	58Cr	74Cr	88Cr	94Cr
EBITA	25Cr	39Cr	54Cr	67Cr	70Cr
EBIT	25Cr	39Cr	54Cr	67Cr	70Cr
EBITDAR	45Cr	59Cr	76Cr	90Cr	96Cr
Effective Tax Rate - (Ratio)	44.24	28.51	20.58	32.02	29.47
Current Domestic Taxes	4.95Cr	6.08Cr	11Cr	15Cr	17Cr
Current Foreign Taxes	12.86L	-4L	-23.7L	3L	-
Total Current Taxes	5.08Cr	6.04Cr	11Cr	15Cr	17Cr
Total Deferred Taxes	-9L	1.28Cr	-3.52Cr	1.16Cr	-48.71L
Normalized Net Income	5.91Cr	14Cr	23Cr	31Cr	33Cr
Interest Capitalized	16.73L	10.62L	7L	-	1T
Interest on Long-Term Debt	14Cr	17Cr	18Cr	18Cr	17Cr
Non-Cash Pension Expense	1L	92T	84T	86T	86T
Supplemental Operating Expense Items
General and Administrative Expenses	71Cr	80Cr	96Cr	111.27Cr	123.68Cr
Research And Development Expense From Footnotes	1.15Cr	1.04Cr	1.06Cr	31.81L	6L
Net Rental Expense, Total	1.15Cr	1.49Cr	1.9Cr	2.44Cr	2.71Cr
Imputed Operating Lease Interest Expense	49.33L	68.1L	82.45L	1.03Cr	1.1Cr
Imputed Operating Lease Depreciation	65.66L	81.19L	1.07Cr	1.41Cr	1.6Cr
Maintenance & Repair Expenses, Total	9.6Cr	11Cr	12Cr	17Cr	18Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	31Cr	47Cr	68Cr	61Cr	100.34Cr
Short Term Investments	5.32Cr	5.34Cr	15Cr	4.88Cr	4Cr
Total Cash And Short Term Investments	37Cr	52Cr	83Cr	66Cr	104.34Cr
Accounts Receivable, Total	34Cr	44Cr	53Cr	57Cr	60Cr
Other Receivables	18Cr	27Cr	17Cr	26Cr	23Cr
Total Receivables	53Cr	71Cr	70Cr	83Cr	82Cr
Inventory	5.38Cr	6.59Cr	7.3Cr	8Cr	9.99Cr
Prepaid Expenses	1.98Cr	2.09Cr	2.4Cr	3.26Cr	3.03Cr
Other Current Assets, Total	-	16Cr	3.52Cr	-	-
Total Current Assets	97Cr	147.14Cr	166.89Cr	160.43Cr	199.66Cr
Gross Property Plant And Equipment	513.61Cr	576.77Cr	594.32Cr	631.4Cr	655.03Cr
Accumulated Depreciation	-131.06Cr	-143.04Cr	-158.29Cr	-172.48Cr	-176.46Cr
Net Property Plant And Equipment	382.55Cr	433.73Cr	436.03Cr	458.92Cr	478.58Cr
Long-term Investments	44Cr	49Cr	52Cr	53Cr	56Cr
Goodwill	19Cr	19Cr	19Cr	19Cr	19Cr
Other Intangibles, Total	3.05Cr	1.66Cr	90.09L	59.67L	1.22Cr
Deferred Tax Assets Long-Term	13Cr	11Cr	13Cr	11Cr	10Cr
Other Long-Term Assets, Total	61Cr	38Cr	38Cr	38Cr	40Cr
Total Assets	618.76Cr	699.41Cr	724.62Cr	740.32Cr	804.52Cr
Liabilities
Accounts Payable, Total	23Cr	24Cr	21Cr	29Cr	26Cr
Accrued Expenses, Total	23Cr	31Cr	34Cr	34Cr	41Cr
Short-term Borrowings	35Cr	31Cr	27Cr	27Cr	22Cr
Current Portion of Long-Term Debt	49Cr	51Cr	26Cr	3.49Cr	2.3Cr
Current Portion of Leases	4.68Cr	6.24Cr	5.84Cr	6.58Cr	7.29Cr
Current Income Taxes Payable	1.83Cr	43.21L	1.11Cr	69.93L	1.03Cr
Unearned Revenue Current, Total	5.09Cr	4.87Cr	8.78Cr	8.32Cr	8.53Cr
Other Current Liabilities	16Cr	19Cr	17Cr	20Cr	23Cr
Total Current Liabilities	158.01Cr	167.35Cr	140.16Cr	129.68Cr	131.64Cr
Long-Term Debt	93Cr	100.93Cr	133.61Cr	130.87Cr	129.01Cr
Long-Term Leases	132.36Cr	185.66Cr	189.92Cr	198.77Cr	235.9Cr
Pension & Other Post Retirement Benefits	23.55L	22.12L	20.69L	21.79L	21.82L
Deferred Tax Liability Non Current	8.16Cr	8.45Cr	6.7Cr	5.89Cr	6.16Cr
Other Non Current Liabilities	1.7Cr	1.37Cr	1.2Cr	1.13Cr	1.09Cr
Total Liabilities	393.71Cr	463.98Cr	471.8Cr	466.56Cr	504.02Cr
Common Stock, Total	96Cr	98Cr	100Cr	100Cr	100Cr
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	105.19Cr	113.01Cr	130.29Cr	146.33Cr	166.03Cr
Treasury Stock	-16Cr	-16Cr	-16Cr	-16Cr	-15Cr
Comprehensive Income and Other	28Cr	28Cr	24Cr	23Cr	24Cr
Total Common Equity	213.54Cr	222.73Cr	238.32Cr	253.67Cr	275.81Cr
Minority Interest	12Cr	13Cr	14Cr	20Cr	25Cr
Total Equity	225.05Cr	235.42Cr	252.82Cr	273.76Cr	300.5Cr
Total Liabilities And Equity	618.76Cr	699.41Cr	724.62Cr	740.32Cr	804.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	434.27Cr	436.43Cr	436.43Cr	436.43Cr	442.63Cr
ECS Total Common Shares Outstanding	432.69Cr	434.32Cr	436.43Cr	436.43Cr	437.39Cr
Book Value / Share	0.49	0.51	0.55	0.58	0.63
Tangible Book Value	191.54Cr	202.12Cr	218.47Cr	234.12Cr	255.65Cr
Tangible Book Value Per Share	0.44	0.47	0.5	0.54	0.58
Total Debt	314.77Cr	375Cr	382.22Cr	367.18Cr	396.46Cr
Net Debt	278Cr	323.16Cr	298.98Cr	301.19Cr	292.12Cr
Debt Equivalent Oper. Leases	9.2Cr	12Cr	15Cr	20Cr	22Cr
Minority Interest, Total (Incl. Fin. Div)	12Cr	13Cr	14Cr	20Cr	25Cr
Equity Method Investments, Total	44Cr	49Cr	51Cr	53Cr	56Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	3L	3L	19.22L	4L	4L
Inventories - Finished Goods, Total	4.99Cr	6.12Cr	6.83Cr	7.45Cr	9.41Cr
Inventories - Others	35.39L	43.3L	27.64L	51.45L	54.06L
Land - (BS)	25Cr	25Cr	25Cr	25Cr	19Cr
Buildings, Total	136.79Cr	150.49Cr	157.5Cr	158.93Cr	127.46Cr
Machinery, Total	164.1Cr	172.38Cr	187.12Cr	207.98Cr	223.26Cr
Full Time Employees	15.25T	16.13T	16.43T	17.32T	16.94T
Accumulated Allowance for Doubtful Accounts (Supple)	3.23Cr	1.53Cr	57.36L	69.59L	46.63L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.1Cr	17Cr	26Cr	35Cr	37Cr
Depreciation & Amortization - CF	24Cr	26Cr	27Cr	28Cr	31Cr
Depreciation & Amortization, Total	24Cr	26Cr	27Cr	28Cr	31Cr
Amortization of Deferred Charges, Total - (CF)	1.15Cr	1.04Cr	1.06Cr	31.81L	6L
(Gain) Loss From Sale Of Asset	52T	-64.17L	-4.52Cr	2L	-4L
(Gain) Loss on Sale of Investments - (CF)	2L	-	-	-	-
Asset Writedown & Restructuring Costs	18.67L	-45.55L	2.41Cr	1.22Cr	91.34L
(Income) Loss On Equity Investments - (CF)	-2.59Cr	-4.78Cr	-4.68Cr	-4.94Cr	-4.88Cr
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	1.16Cr	-57.55L	72.71L	86.48L	34.87L
Net Cash From Discontinued Operations	-	-77.74L	-3.18Cr	-10L	2L
Other Operating Activities, Total	16Cr	18Cr	22Cr	17Cr	23Cr
Change In Accounts Receivable	-5.42Cr	-17Cr	-3.32Cr	-8.97Cr	-2.67Cr
Change In Inventories	-23.28L	-1.27Cr	-75.3L	-75.72L	-2.14Cr
Change In Accounts Payable	1.48Cr	9.62Cr	-1.74Cr	16Cr	6.98Cr
Change in Unearned Revenues	-50.56L	-22.33L	3.91Cr	2L	30.34L
Cash from Operations	41Cr	46Cr	66Cr	84Cr	89Cr
Capital Expenditure	-22Cr	-23Cr	-24Cr	-38Cr	-27Cr
Sale of Property, Plant, and Equipment	7L	20Cr	2.23Cr	18.28L	24Cr
Cash Acquisitions	-	-	-	-	-
Divestitures	15.6L	-	1.98Cr	36.76L	-17.65L
Sale (Purchase) of Real Estate properties	-3L	-	-	-	-
Sale (Purchase) of Intangible assets	-2L	-	-30.1L	-1L	-68.68L
Investment in Marketable and Equity Securities, Total	-5L	-2.5Cr	-	-	-
Other Investing Activities, Total	25Cr	3.81Cr	10Cr	14Cr	5.08Cr
Cash from Investing	3.78Cr	-2.58Cr	-9.46Cr	-23Cr	1.27Cr
Long-Term Debt Issued, Total	24Cr	84Cr	71Cr	11Cr	8.26Cr
Total Debt Issued	24Cr	84Cr	71Cr	11Cr	8.26Cr
Long-Term Debt Repaid, Total	-50Cr	-95Cr	-83Cr	-51Cr	-34Cr
Total Debt Repaid	-50Cr	-95Cr	-83Cr	-51Cr	-34Cr
Issuance of Common Stock	4.29Cr	1.49Cr	1.92Cr	-	2.48Cr
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-2.37Cr	-8.69Cr	-15Cr	-18Cr	-18Cr
Common & Preferred Stock Dividends Paid	-2.37Cr	-8.69Cr	-15Cr	-18Cr	-18Cr
Other Financing Activities, Total	-15Cr	-10Cr	-18Cr	1.11Cr	-8.21Cr
Cash from Financing	-39Cr	-29Cr	-43Cr	-57Cr	-50Cr
Foreign Exchange Rate Adjustments	-11.95L	-5L	74.46L	-8L	-13.82L
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	5.5Cr	15Cr	14Cr	4.18Cr	40Cr
Supplemental Items
Cash Interest Paid	9.05Cr	9.21Cr	9.72Cr	8.79Cr	7.93Cr
Cash Income Tax Paid (Refund)	5.89Cr	9.2Cr	7.64Cr	18Cr	14Cr
Levered Free Cash Flow	5.54Cr	15Cr	39Cr	20Cr	42Cr
Unlevered Free Cash Flow	16Cr	28Cr	52Cr	32Cr	54Cr
Change In Net Working Capital	3.52Cr	10.63L	-14Cr	11.81L	-7.07Cr
Net Debt Issued / Repaid	-26Cr	-11Cr	-13Cr	-40Cr	-26Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.54	3.7	4.74	5.72	5.7
Return on Total Capital	2.91	4.24	5.42	6.57	6.58
Return On Equity %	2.95	8.27	12.4	13.85	13.98
Return on Common Equity	2.44	7.88	12.2	13.46	13.83
Margin Analysis
Gross Profit Margin %	35.79	40.04	41.88	44.75	44.57
SG&A Margin	27.19	27.49	28.06	28.37	29.04
EBITDA Margin %	16.61	19.85	21.58	22.4	21.99
EBITA Margin %	9.54	13.35	15.79	17.09	16.53
EBIT Margin %	9.54	13.35	15.79	17.09	16.53
Income From Continuing Operations Margin %	2.5	6.52	8.85	9.3	9.43
Net Income Margin %	1.94	5.89	7.7	9.02	8.59
Net Avail. For Common Margin %	1.94	5.89	8.23	8.44	8.6
Normalized Net Income Margin	2.25	4.81	6.72	7.82	7.67
Levered Free Cash Flow Margin	2.11	5.27	11.47	5.03	9.92
Unlevered Free Cash Flow Margin	6.09	9.45	15.22	8.17	12.78
Asset Turnover
Asset Turnover	0.43	0.44	0.48	0.54	0.55
Fixed Assets Turnover	0.68	0.72	0.79	0.88	0.91
Receivables Turnover (Average Receivables)	8.19	7.45	7.05	7.1	7.28
Inventory Turnover (Average Inventory)	31.88	29.28	28.61	28.32	26.23
Short Term Liquidity
Current Ratio	0.61	0.88	1.19	1.24	1.52
Quick Ratio	0.57	0.73	1.1	1.15	1.42
Operating Cash Flow to Current Liabilities	0.26	0.27	0.47	0.65	0.68
Days Sales Outstanding (Average Receivables)	44.55	48.99	51.74	51.56	50.16
Days Outstanding Inventory (Average Inventory)	11.45	12.47	12.76	12.92	13.91
Average Days Payable Outstanding	52.05	48.98	40.86	41.78	42.41
Cash Conversion Cycle (Average Days)	3.95	12.48	23.64	22.7	21.66
Long Term Solvency
Total Debt/Equity	139.87	159.29	151.18	134.12	131.93
Total Debt / Total Capital	58.31	61.43	60.19	57.29	56.88
LT Debt/Equity	100.25	121.74	127.97	120.41	121.43
Long-Term Debt / Total Capital	41.79	46.95	50.95	51.43	52.36
Total Liabilities / Total Assets	63.63	66.34	65.11	63.02	62.65
EBIT / Interest Expense	1.5	1.99	2.63	3.4	3.62
EBITDA / Interest Expense	2.96	3.31	3.96	4.82	5.22
(EBITDA - Capex) / Interest Expense	1.66	2.11	2.8	2.89	3.83
Total Debt / EBITDA	6.37	5.8	4.71	3.87	3.91
Net Debt / EBITDA	5.62	4.99	3.69	3.17	2.88
Total Debt / (EBITDA - Capex)	11.33	9.08	6.67	6.44	5.33
Net Debt / (EBITDA - Capex)	10.01	7.83	5.21	5.28	3.93
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.57	12.77	19.18	14.73	9.21
Gross Profit, 1 Yr. Growth %	4.16	26.31	22.17	22.59	8.55
EBITDA, 1 Yr. Growth %	-8.21	31.28	23.91	19.07	6.49
EBITA, 1 Yr. Growth %	-17.22	52.36	33.1	24.16	4.89
EBIT, 1 Yr. Growth %	-17.22	52.36	33.1	24.16	4.89
Earnings From Cont. Operations, 1 Yr. Growth %	-40.75	162.97	49.85	20.54	9.75
Net Income, 1 Yr. Growth %	-53.79	213.94	57.75	34.32	3.42
Normalized Net Income, 1 Yr. Growth %	-44.36	135.74	57.28	33.45	6.3
Diluted EPS Before Extra, 1 Yr. Growth %	-53.23	212.1	60.45	17.61	9.86
Accounts Receivable, 1 Yr. Growth %	16.39	27.28	20.78	8.39	3.62
Inventory, 1 Yr. Growth %	3.27	22.55	10.83	9.58	24.93
Net Property, Plant and Equip., 1 Yr. Growth %	-2.28	13.38	0.53	5.25	4.28
Total Assets, 1 Yr. Growth %	0.75	13.03	3.6	2.17	8.67
Tangible Book Value, 1 Yr. Growth %	5.58	5.52	8.09	7.17	9.19
Common Equity, 1 Yr. Growth %	4.16	4.3	7	6.44	8.73
Cash From Operations, 1 Yr. Growth %	22.41	11.54	43.01	28.42	6.42
Capital Expenditures, 1 Yr. Growth %	-9.95	8.13	1.41	59.62	-28.65
Levered Free Cash Flow, 1 Yr. Growth %	-4.16T	-180.44	138.54	-49.65	113.41
Unlevered Free Cash Flow, 1 Yr. Growth %	58.63	-417.35	81.99	-38.37	69.41
Dividend Per Share, 1 Yr. Growth %	-54.17	263.64	55	33.87	-0.48
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.05	10.37	14.89	16.93	11.61
Gross Profit, 2 Yr. CAGR %	-7.98	13.83	24.36	22.38	15.13
EBITDA, 2 Yr. CAGR %	-9.95	10.42	29.26	21.47	12.66
EBITA, 2 Yr. CAGR %	-18.69	13.47	45.25	28.55	14.19
EBIT, 2 Yr. CAGR %	-18.69	13.47	45.25	28.55	14.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-46.19	31.05	104.47	34.4	15.2
Net Income, 2 Yr. CAGR %	-50.86	24.79	119.27	45.56	17.86
Normalized Net Income, 2 Yr. CAGR %	-38.94	15.07	96.36	44.88	19.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-50.53	24.92	128.07	37.37	13.85
Accounts Receivable, 2 Yr. CAGR %	-4.22	21.71	23.99	14.42	5.98
Inventory, 2 Yr. CAGR %	0.13	12.49	16.54	10.2	17
Net Property, Plant and Equip., 2 Yr. CAGR %	1.92	5.26	6.76	2.86	4.77
Total Assets, 2 Yr. CAGR %	1.67	6.72	8.22	2.88	5.37
Tangible Book Value, 2 Yr. CAGR %	7.5	5.55	6.8	7.63	8.17
Common Equity, 2 Yr. CAGR %	6.22	4.23	5.64	6.72	7.58
Cash From Operations, 2 Yr. CAGR %	-15.75	16.85	26.3	35.52	16.56
Capital Expenditures, 2 Yr. CAGR %	-26.18	-1.32	4.72	27.23	6.72
Levered Free Cash Flow, 2 Yr. CAGR %	-22.78	961.62	43.22	9.59	3.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.81	65.48	144.56	5.9	2.26
Dividend Per Share, 2 Yr. CAGR %	-47.56	29.1	137.41	44.05	15.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.93	2.18	12.56	14.84	14.08
Gross Profit, 3 Yr. CAGR %	-3.2	1.75	16.63	23.77	17.43
EBITDA, 3 Yr. CAGR %	-1.23	2.51	15.78	25.77	16.29
EBITA, 3 Yr. CAGR %	-5.95	0.94	21.26	37.85	20.18
EBIT, 3 Yr. CAGR %	-5.95	0.94	21.26	37.85	20.18
Earnings From Cont. Operations, 3 Yr. CAGR %	-29.35	-5.66	39.77	71.45	25.75
Net Income, 3 Yr. CAGR %	-34.24	-6.64	33.61	86.23	29.89
Normalized Net Income, 3 Yr. CAGR %	-27.8	-3.92	29.38	72.64	30.75
Diluted EPS Before Extra, 3 Yr. CAGR %	-32.13	-6.54	37.52	82.89	27.64
Accounts Receivable, 3 Yr. CAGR %	-1.83	5.3	21.4	18.55	10.7
Inventory, 3 Yr. CAGR %	2.33	7.11	11.94	14.17	14.91
Net Property, Plant and Equip., 3 Yr. CAGR %	16.33	5.6	3.66	6.25	3.33
Total Assets, 3 Yr. CAGR %	8.89	5.33	5.67	6.16	4.78
Tangible Book Value, 3 Yr. CAGR %	3.11	6.84	6.39	6.92	8.15
Common Equity, 3 Yr. CAGR %	2.48	5.57	5.15	5.91	7.39
Cash From Operations, 3 Yr. CAGR %	-7.34	-7.49	24.99	27	24.79
Capital Expenditures, 3 Yr. CAGR %	-17.11	-16.16	-0.42	20.52	4.92
Levered Free Cash Flow, 3 Yr. CAGR %	-17.14	18.32	559.93	1.08	36.98
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.2	12.8	72.81	54.47	23.92
Dividend Per Share, 3 Yr. CAGR %	-34.97	0	37.21	96.14	27.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.42	-1.69	0.31	7.45	12.18
Gross Profit, 5 Yr. CAGR %	1.22	3.91	6.68	9.59	16.03
EBITDA, 5 Yr. CAGR %	2.85	8.51	10.25	10.3	14.52
EBITA, 5 Yr. CAGR %	-0.12	8.43	12.37	12.07	18.38
EBIT, 5 Yr. CAGR %	-0.12	8.43	12.37	12.07	18.38
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.69	1.89	10.2	9.98	29.37
Net Income, 5 Yr. CAGR %	-19.31	1.22	7.98	10.85	27.07
Normalized Net Income, 5 Yr. CAGR %	-14.32	0.35	7.93	14.13	25.21
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.74	3.11	11.7	9.86	27.51
Accounts Receivable, 5 Yr. CAGR %	-1.79	1.24	7.78	8.86	14.98
Inventory, 5 Yr. CAGR %	2.67	5.22	7.79	8.34	13.94
Net Property, Plant and Equip., 5 Yr. CAGR %	14.23	14.48	12.4	4.5	4.1
Total Assets, 5 Yr. CAGR %	9.47	10.56	8.62	4.34	5.55
Tangible Book Value, 5 Yr. CAGR %	7.25	6.33	4.57	7.15	7.1
Common Equity, 5 Yr. CAGR %	6.01	5.22	3.74	6.03	6.11
Cash From Operations, 5 Yr. CAGR %	23.54	4.88	4.88	7.77	21.55
Capital Expenditures, 5 Yr. CAGR %	-3.44	-12.28	-8.99	-0.94	2.38
Levered Free Cash Flow, 5 Yr. CAGR %	-22.15	-13.1	32.15	16.29	214.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.19	1.18	27.52	10.76	40.1
Dividend Per Share, 5 Yr. CAGR %	-14.59	2.36	9.16	15.72	28.04